Skip to main content
Dates: May 14 [Wed] - 16 [Fri], 2014
Venue: Tokyo Big Sight Organised by: Reed Exhibitions Japan Ltd.
Co-held with: 1st Personalised Medicine & Diagnostics Expo (IVD Japan 2014)
President & CEO,
Chiome Bioscience Inc.
[Abstract]In therapeutic antibody development, the market is expected to show continuous growth, however, there remains several challenges to be solved. I will talk about the latest trends in development of therapeutic antibodies and challenges for further growth in this field.
Professor, Dept. of Tumor Immunology,
Aichi Medical University School of Medicine
[Abstract]There have been great expectations for the progress of collaborative translational research by industry, agency and academia for many years. However, it is rare to see their successful cases in Japan. The key factors for success, as well as potential issues/pitfalls will be discussed from our experience of clinical translational research for Mogamulizumab, an antibody drug discovered and developed in Japan.
-(Honorifics omitted) Please note that the speakers and programs are subject to change.The photographic and video recording rights are reserved to the Show Management.About BIO tech 2013 email@example.com